DRMCRL research presented at the 3rd Nuclear Receptors Conference, 4 -7 May 2022

Posted on May 6 2022 by a1090031

DRMCRL Director, Prof Wayne Tilley and Prof Charlotte Bevan (Imperial College London) co-chaired the 3rd Nuclear Receptor meeting, which returned to a face to face format in Cancun, Mexico, after being postponed for the last two years.

The current breast and prostate research being undertaken at the DRMCRL was presented by

Assoc Prof Theresa Hickey – "Coming in sideways to target ERα", and
Dr Amy Dwyer –"Reprogramming nuclear receptor signalling in breast and prostate cancer".

#NR2022

Tagged in androgen receptor, breast cancer, prostate cancer, fusion conference